RBV Capital


Alexei Repik will earn a couple of tens of millions of dollars in the US market


R-Pharm and the Russian Venture Company invested $ 4 million in the American company Bonti, which develops drugs for aesthetic medicine, and will receive up to $ 20 million when it is sold to the Irish giant Allergan.